Skip to main content

Table 1 The H19 and IGF2-P4 overall expression in TCC tissue samples determined by RT-PCR (n = 39) and by in situ hybridization (ISH) (n = 28)

From: Development of targeted therapy for bladder cancer mediated by a double promoter plasmid expressing diphtheria toxin under the control of H19 and IGF2-P4 regulatory sequences

 

RT-PCR

ISH

Total

IGF2-P4

38/39

24/28

62/67

H19

37/39

27/28

64/67